Effects of Microcurrent Treatment With and Without Resistance Exercises
Launched by UNIVERSITY OF GREENWICH · Sep 30, 2022
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called microcurrent therapy, both by itself and when combined with a resistance exercise program, to see how it impacts muscle strength, body composition, and overall physical ability in middle-aged adults. The aim is to help people aged 40 to 65 who do not regularly exercise, particularly those concerned about losing muscle strength as they age, a condition known as sarcopenia.
Participants in the trial will be randomly assigned to one of four groups: some will receive microcurrent treatment alone, some will do microcurrent therapy along with resistance exercises, and others will receive a sham treatment (which looks like the real treatment but has no active effect), either alone or with exercises. Those who choose to participate in the exercise program will attend two training sessions each week for six weeks, using elastic bands to help build strength. Throughout the trial, participants will undergo various measurements to track changes in their muscle and body composition. To be eligible, participants must be healthy adults between 40 and 65 years old and should not have any injuries, chronic health conditions, or be taking certain supplements that could affect physical performance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • non-regularly trained male and female adults, aged 40 to 65 years old.
- Exclusion Criteria:
- • with no musculoskeletal injuries, metabolic conditions, or diseases or currently taking medications, smoking, and nutritional supplements known to affect physical performance, muscle damage or recovery processes (e.g., creatine, whey protein, and amino acids, vitamin, or mineral supplementation, etc.) within 6 weeks prior to the start of the study.
About University Of Greenwich
The University of Greenwich is a leading academic institution dedicated to advancing knowledge and innovation through rigorous research and clinical trials. With a commitment to high standards of ethical practice and scientific integrity, the university fosters interdisciplinary collaboration among its faculty and students to address pressing health challenges. By leveraging its state-of-the-art facilities and expertise, the University of Greenwich aims to contribute valuable insights to the medical field, enhance patient outcomes, and support the development of new therapies through robust clinical trial methodologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Fernando Naclerio, PhD
Principal Investigator
University of Greenwich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials